1. Home
  2. TLSI vs SPIR Comparison

TLSI vs SPIR Comparison

Compare TLSI & SPIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSI
  • SPIR
  • Stock Information
  • Founded
  • TLSI 2010
  • SPIR 2012
  • Country
  • TLSI United States
  • SPIR United States
  • Employees
  • TLSI N/A
  • SPIR N/A
  • Industry
  • TLSI Medical Specialities
  • SPIR Telecommunications Equipment
  • Sector
  • TLSI Health Care
  • SPIR Consumer Discretionary
  • Exchange
  • TLSI Nasdaq
  • SPIR Nasdaq
  • Market Cap
  • TLSI 166.8M
  • SPIR 201.1M
  • IPO Year
  • TLSI N/A
  • SPIR N/A
  • Fundamental
  • Price
  • TLSI $4.62
  • SPIR $10.41
  • Analyst Decision
  • TLSI Strong Buy
  • SPIR Buy
  • Analyst Count
  • TLSI 3
  • SPIR 6
  • Target Price
  • TLSI $12.67
  • SPIR $14.20
  • AVG Volume (30 Days)
  • TLSI 72.3K
  • SPIR 337.5K
  • Earning Date
  • TLSI 11-12-2024
  • SPIR 11-06-2024
  • Dividend Yield
  • TLSI N/A
  • SPIR N/A
  • EPS Growth
  • TLSI N/A
  • SPIR N/A
  • EPS
  • TLSI N/A
  • SPIR N/A
  • Revenue
  • TLSI $24,736,000.00
  • SPIR $107,223,000.00
  • Revenue This Year
  • TLSI $61.24
  • SPIR $19.74
  • Revenue Next Year
  • TLSI $47.32
  • SPIR $22.65
  • P/E Ratio
  • TLSI N/A
  • SPIR N/A
  • Revenue Growth
  • TLSI 67.75
  • SPIR 24.15
  • 52 Week Low
  • TLSI $3.32
  • SPIR $3.27
  • 52 Week High
  • TLSI $10.42
  • SPIR $19.40
  • Technical
  • Relative Strength Index (RSI)
  • TLSI 35.17
  • SPIR 61.31
  • Support Level
  • TLSI $4.54
  • SPIR $7.87
  • Resistance Level
  • TLSI $5.08
  • SPIR $8.60
  • Average True Range (ATR)
  • TLSI 0.35
  • SPIR 0.66
  • MACD
  • TLSI -0.04
  • SPIR 0.38
  • Stochastic Oscillator
  • TLSI 18.66
  • SPIR 91.79

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

About SPIR Spire Global Inc.

Spire Global Inc is a provider of space-based data, analytics, and Space Services, offering datasets and powerful insights about Earth from the ultimate vantage point of space so that organizations can make decisions with confidence, accuracy, and speed. It generates revenue from four solutions: Maritime, Aviation, Weather, and Space Services. It offers the following three data solutions to customers; Maritime-precise space-based data used for accurate ship monitoring, ship safety, and route optimization, Aviation-precise space-based data used for accurate aircraft monitoring, aircraft safety, and route optimization, and Weather-precise space-based data used for accurate weather forecasting.

Share on Social Networks: